CUE
Cue Biopharma
24.70$
-3.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.6% | -0.2% | +1.5% | +1.7% | -127.1% | – | -9.8% | -25.1% | +144.8% | -61.2% | -93.6% | – | |
| – | 0.0% | -6.1% | -9.8% | -9.8% | -1.3% | -14.3% | -5.6% | +21.4% | -60.2% | -92.1% | +49,562.5% | – | |
| – | -363.0% | – | – | – | – | – | +62.6% | -221.9% | – | – | – | – | |
| – | – | – | -81.8% | -90.0% | +100.0% | +7,400.0% | -82.0% | -100.0% | – | – | -100.0% | – | |
| – | – | – | -81.8% | – | -101.0% | +14,900.0% | -82.0% | +24,966.7% | – | -101.7% | – | – | |
| – | – | – | – | – | -0.1% | +0.1% | +0.0% | +0.0% | +50.0% | -100.0% | – | – | |
| – | +4.2% | -50.8% | -142.5% | – | -109.5% | +7.3% | – | -100.0% | +949,100.0% | -96.8% | +9,709.5% | – | |
| – | -445.0% | – | – | – | -516.4% | – | – | -210.0% | – | -169.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.